" /> Androgen Receptor Ligand-binding Domain-encoding Plasmid DNA Vaccine MVI-118 - CISMeF





Preferred Label : Androgen Receptor Ligand-binding Domain-encoding Plasmid DNA Vaccine MVI-118;

NCIt synonyms : AR LBD-encoding Plasmid DNA Vaccine MVI-118; pTVG-AR Vaccine; pTVG-AR;

NCIt definition : A cancer vaccine containing pTVG4 plasmid DNA encoding the human androgen receptor (AR) ligand-binding domain (LBD) (pTVG-AR), with potential immunostimulating and antineoplastic activities. Upon intradermal administration of AR LBD-encoding plasmid DNA vaccine MVI-118, the plasmid DNA vaccine expresses AR LBD and may stimulate the host immune system to generate a cytotoxic T-lymphocyte (CTL) response against AR LBD-expressing prostate cancer cells. This reduces proliferation of AR-expressing tumor cells. AR, a tumor-associated antigen (TAA) overexpressed in prostate cancer cells, plays a key role in the development and progression of prostate cancer; its expression is correlated with poor prognosis.;

Molecule name : MVI-118;

Details


You can consult :


Nous contacter.
12/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.